Aurinia Pharmaceuticals Announces Post-Merger Leadership Changes and Strategic Restructuring
October 22, 2013 07:45 ET
|
Aurinia Pharmaceuticals Inc.
VICTORIA, British Columbia, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc., now operating as Aurinia Pharmaceuticals Inc. (TSX-V:ISA) ("Aurinia" or the "Company"), announced today a...
Isotechnika Pharma Inc. Common Shares to Commence Trading on the TSX-V as of September 30, 2013
September 26, 2013 08:00 ET
|
Aurinia Pharmaceuticals Inc.
VICTORIA, British Columbia, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc., now operating as Aurinia Pharmaceuticals Inc. (TSX:ISA) ("Aurinia" or the "Company"), announced that, further to...
Isotechnika and Aurinia Complete Merger and Financing
September 23, 2013 08:00 ET
|
Aurinia Pharmaceuticals Inc.
VICTORIA, British Columbia, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") announced today that it has completed the merger and related transactions (the "Merger...
Isotechnika Shareholders Approve Merger With Aurinia at Annual and Special Meeting
August 16, 2013 08:30 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, Aug. 16, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced that at its Annual and Special Meeting of Shareholders held on August...
Isotechnika Reports Second Quarter 2013 Financial Results
August 13, 2013 18:46 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the second quarter ended June 30, 2013.
Recent...
Isotechnika to Hold Annual and Special Meeting of Shareholders on August 15
July 25, 2013 08:30 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, July 25, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued a further...
Isotechnika Provides Further Merger and Financings Update
June 27, 2013 07:45 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, June 27, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued a further...
Isotechnika Pharma Receives Additional Funding From the Government of Canada for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent
June 18, 2013 07:45 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, June 18, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") today announced that it has received additional funding from the National...
Isotechnika Reports First Quarter 2013 Financial Results
May 15, 2013 17:00 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, May 15, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the first quarter ended March 31, 2013.
Recent...
Isotechnika Provides Merger Update and Announces Financings
April 17, 2013 08:25 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, April 17, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued an update...